UNSPSC 51182400: Calcium regulators and calcium salts

This classification denotes typically ionic compounds derived via neutralization, in this case of the mineral calcium, such as calcium acetate, calcium chloride, calcium glucoheptonate or calcium gluceptate, calcium gluconate, calcium glycero phosphate, calcium lactate, calcium salts and calcium regulators, dibase calcium phosphate, or tribasic calcium phosphate.

UNSPSC 51182400 Calcium regulators and calcium salts is a Class code encompassing pharmaceutical products supplied to state and local government health facilities, though the recent solicitation activity shows broader multistate cooperative purchasing of generic pharmaceuticals and over-the-counter products rather than calcium-specific formulations alone. State and local governments procure these products through cooperative purchasing alliances and direct vendor relationships to stock health departments, correctional facilities, public hospitals, and other government-operated medical settings. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body visible in recent activity, serving multiple participating states including Oregon. Vendors supplying under this code must maintain cGMP certification, comply with the Drug Supply Chain Security Act, establish relationships with authorized pharmaceutical wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co.), and meet comprehensive insurance requirements including $5 million commercial general liability coverage and $2 million network security and privacy liability coverage.

MMCAP issued a Request for Proposal (RFP) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, with a two-year initial term and optional extensions through June 30, 2028 for incumbent responders. The evaluation emphasizes price competitiveness at 75 percent weighting, with the remaining 25 percent distributed across fixed pricing structure, administrative fee compliance, EDI capability, and agreement to a 3 percent administrative fee. Vendors must supply detailed product information including NDC codes, SKUs, UPCs, and manufacturing locations, and submit pricing through multiple formats (flat price, net price, or WAC-minus structures) via the ePro procurement system. All products must possess FDA approval and at least one-year expiration dates with six-month minimum shelf life from the May 15, 2026 availability requirement. The solicitation carries performance penalties ranging from $200 to $1,500 per violation for reporting delays, onboarding failures, or improper trade-class denials, and no specific set-aside designations or disadvantaged-enterprise restrictions were disclosed in the available documentation.